News Releases

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘Leukemia’ clear

  • The pre-cancerous blood disorder myelodsysplastic syndrome (MDS) affects between 35,000 and 55,000 people in the United States. Dana-Farber's David Steensma, MD, discusses MDS and its treatment.

Tags: StemCellTransplant, Leukemia

  • Dana-Farber researchers have developed a method for determining how ready acute myeloid leukemia cells are to die, a finding that may enable oncologists to choose more effective treatments for their patients.

Tags: BasicResearch, StemCellTransplant, Leukemia

  • Dana-Farber scientists have safely shut down breast cancer and a form of leukemia in mice by targeting abnormal proteins to which the cancers are "addicted."

Tags: BasicResearch, BreastCancer, Leukemia

  • Pediatric patients with B-precursor acute lymphoblastic leukemia who are likely to relapse after chemotherapy treatment can reduce those odds by receiving additional courses of chemotherapy, according to research by Dana-Farber/Children's Hospital Cancer Center investigators.

Tags: chemotherapy, ChildhoodCancer, Leukemia

  • Dana-Farber researchers found that an experimental drug combination for preventing graft-versus-host disease (GVHD) was not significantly better than the standard regimen of care, but that the new combination could provide an alternative that could be preferable in certain scenarios.

Tags: GraftVersusHost, StemCellTransplant, Leukemia

  • Dana-Farber and Broad Institute researchers for the first time are able to show the past, present, and future of CLL tumors.

Tags: Genetics, Leukemia

  • Dana-Farber investigators led a phase 1 trial in which a new oral targeted drug, idelalisib, (GS-1101), showed the potential to stave off the need for additional treatments for relapsed or treatment-resistant CLL.

Tags: Leukemia

  • The Leukemia & Lymphoma Society and Dana-Farber joined together to establish the Blood Cancer Research Partnership, an innovative program bringing together a network of sites for clinical trial testing of blood cancer therapies in community oncology settings across the country.

Tags: Leukemia, Lymphoma

  • Dana-Farber Cancer Institute scientists provide the first statistically-based guidelines for determining whether stem cell transplant is appropriate for patients older than 60 with myelodysplastic syndromes (MDS)

Tags: StemCellTransplant, Leukemia

  • Dana-Farber scientists report in the Journal of Clinical Investigation they have developed a tumor vaccine based on the patient’s tumor to create a strong and selective immune response in some chronic lymphocytic leukemia patients.

Tags: ImmuneSystem, Leukemia

Showing 11-20 of 26 items